Skip to content

Applied Research of VR+Eye-Tracking Technology for Cognitive Function Screening

Applied Research of VR+Eye-Tracking Technology for Cognitive Function Screening

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126081
Enrollment
Unknown
Registered
2026-06-03
Start date
2025-08-31
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild cognitive impairment

Interventions

Gold Standard:MoCA and MMSE scale evaluations conducted by professionals
Index test:VR+ eye movement screening task. Group A first underwent VR+ eye movement screening tasks, and then professional assessors conducted MoCA and MMSE. Group B first underwent MoCA and MMSE, an

Sponsors

Xuanwu Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age 50 or older, both men and women, no educational restrictions; 2.No conditions affecting neuropsychological testing, such as aphasia, hemiplegia on the dominant side, severe hearing or visual impairments; 3.Unrestricted use of dominant hand, capable of drawing simple shapes with a pen; 4.Patient-reported or informant-reported cognitive decline within the past year; 5.No prior MoCA or MMSE assessment within the past 6 months; 6.Normal vision or corrected vision within normal range; 7.Signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Individuals exhibiting obvious neurological impairment symptoms or signs who are unable to cooperate with the assessment; 2.Individuals with significant psychiatric behavioral abnormalities or other physical illnesses who cannot complete the assessment; 3.Individuals with alcohol abuse or currently taking medications that impair cognitive function (e.g., antihistamines, antipsychotics); 4.History of stroke or traumatic brain injury within the past 6 months; 5.Undergone general anesthesia surgery within the past 6 months; 6.Visual impairments or ocular diseases (e.g., amblyopia, presbyopia, corneal or retinal disorders) and history of ocular surgery; 7.Uncorrected or poorly corrected visual abnormalities preventing satisfactory calibration of VR devices to adequate clarity.

Design outcomes

Primary

MeasureTime frame
The AI-MoCA and AI-MMSE scores obtained from the VR+ eye-tracking screening task ;Montreal Cognitive Assessment (MoCA) ;Mini-Mental State Examination (MMSE) ;

Countries

China

Contacts

Public ContactChu Xi

Xuanwu Hospital, Capital Medical University

lishiyi@66nao.com+86 139 1002 9769

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026